Physical Functioning in Heart Failure With Preserved Ejection Fraction

被引:4
作者
Cosiano, Michael F. [1 ]
Tobin, Rachel [1 ]
Mentz, Robert J. [2 ,3 ]
Greene, Stephen J. [2 ,3 ]
机构
[1] Duke Univ, Sch Med, Dept Internal Med, Durham, NC USA
[2] Duke Univ, Div Cardiol, Sch Med, Durham, NC USA
[3] Duke Clin Res Inst, 200 Morris St, Durham, NC 27701 USA
关键词
Physical functioning; HFpEF; quality of life; QUALITY-OF-LIFE; CITY CARDIOMYOPATHY QUESTIONNAIRE; LOWER-EXTREMITY FUNCTION; EXERCISE CAPACITY; SYSTOLIC FUNCTION; ELDERLY-PATIENTS; OLDER PATIENTS; GAIT SPEED; WALK TEST; PERFORMANCE-MEASURES;
D O I
10.1016/j.cardfail.2021.04.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent, yet interventions and therapies to improve outcomes remain limited. There has been increasing attention towards the impact of comorbidities and physical functioning (PF) on poor clinical outcomes within this population. In this review, we summarize and discuss the literature on PF in HFpEF, its association with clinical and patient- centered outcomes, and future advances in the care of HFpEF with respect to PF. Multiple PF metrics have been demonstrated to provide prognostic value within HFpEF, yet the data are less robust compared with other patient populations, highlighting the need for further investigation. The evaluation and detection of poor PF provides a potential strategy to improve care in HFpEF, and future studies are needed to under- stand if modulating PF improves clinical and/or patient-reported outcomes. Lay Summary: Patients with heart failure with preserved ejection fraction (HFpEF) commonly have impaired physical functioning (PF) demonstrated by limitations across a wide range of common PF metrics. Impaired PF metrics demonstrate prognostic value for both clinical and patient-reported outcomes in HFpEF, making them plausible therapeutic targets to improve outcomes. Clinical trials are ongoing to investigate novel methods of detecting, monitoring, and improving impaired PF to enhance HFpEF care. Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent, yet interventions and therapies to improve outcomes remain limited. As such, there has been increasing focus on the impact of physical performance (PF) on clinical and patient-centered outcomes. In this review, we discuss the state of PF in patients with HFpEF by examining the multitude of PF metrics available, their respective strengths and limitations, and their associations with outcomes in HFpEF. We highlight future advances in the care of HFpEF with respect to PF, particularly regarding the evaluation and detection of poor PF.
引用
收藏
页码:1002 / 1016
页数:15
相关论文
共 128 条
  • [1] Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure
    Ahmad, Faraz S.
    Kallen, Michael A.
    Schifferdecker, Karen E.
    Carluzzo, Kathleen L.
    Yount, Susan E.
    Gelow, Jill M.
    McCullough, Peter A.
    Kimmel, Stephen E.
    Fisher, Elliot S.
    Cella, David
    [J]. CIRCULATION-HEART FAILURE, 2019, 12 (06)
  • [2] Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function
    Ahmed, A
    Aronow, WS
    Fleg, JL
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (02) : 444 - 450
  • [3] Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
    Ahmeti, Artan
    Henein, Michael Y.
    Ibrahimi, Pranvera
    Elezi, Shpend
    Haliti, Edmond
    Poniku, Afrim
    Batalli, Arlind
    Bajraktari, Gani
    [J]. BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [4] Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction
    Angraal, Suveen
    Mortazavi, Bobak J.
    Gupta, Aakriti
    Khera, Rohan
    Ahmad, Tariq
    Desai, Nihar R.
    Jacoby, Daniel L.
    Masoudi, Frederick A.
    Spertus, John A.
    Krumholz, Harlan M.
    [J]. JACC-HEART FAILURE, 2020, 8 (01) : 12 - 21
  • [5] Prevalence, Clinical Phenotype, and Outcomes Associated With Normal B-Type Natriuretic Peptide Levels in Heart Failure With Preserved Ejection Fraction
    Anjan, Venkatesh Y.
    Loftus, Timothy M.
    Burke, Michael A.
    Akhter, Nausheen
    Fonarow, Gregg C.
    Gheorghiade, Mihai
    Shah, Sanjiv J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06) : 870 - 876
  • [6] The oxygen uptake efficiency slope is reduced in older patients with heart failure and a normal ejection fraction
    Arena, Ross
    Brubaker, Peter
    Moore, Brian
    Kitzman, Dalane
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (01) : 101 - 102
  • [7] Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction The VITALITY-HFpEF Randomized Clinical Trial
    Armstrong, Paul W.
    Lam, Carolyn S. P.
    Anstrom, Kevin J.
    Ezekowitz, Justin
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Pieske, Burkert
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Solomon, Scott D.
    Voors, Adriaan A.
    She, Lilin
    Vlajnic, Vanja
    Carvalho, Francine
    Bamber, Luke
    Blaustein, Robert O.
    Roessig, Lothar
    Butler, Javed
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (15): : 1512 - 1521
  • [8] Exercise capacity, breathing pattern, and gas exchange during exercise for patients with isolated diastolic dysfunction
    Arruda, Ana Lucia M.
    Pellikka, Patricia A.
    Olson, Thomas P.
    Johnson, Bruce D.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2007, 20 (07) : 838 - 846
  • [9] Clinician's Guide to Cardiopulmonary Exercise Testing in Adults A Scientific Statement From the American Heart Association
    Balady, Gary J.
    Arena, Ross
    Sietsema, Kathy
    Myers, Jonathan
    Coke, Lola
    Fletcher, Gerald F.
    Forman, Daniel
    Franklin, Barry
    Guazzi, Marco
    Gulati, Martha
    Keteyian, Steven J.
    Lavie, Carl J.
    Macko, Richard
    Mancini, Donna
    Milani, Richard V.
    [J]. CIRCULATION, 2010, 122 (02) : 191 - 225
  • [10] Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life
    Bekfani, Tarek
    Pellicori, Pierpaolo
    Morris, Daniel A.
    Ebner, Nicole
    Valentova, Miroslava
    Steinbeck, Lisa
    Wachter, Rolf
    Elsner, Sebastian
    Sliziuk, Veronika
    Schefold, Joerg C.
    Sandek, Anja
    Doehner, Wolfram
    Cleland, John G.
    Lainscak, Mitja
    Anker, Stefan D.
    von Haehling, Stephan
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 41 - 46